Nasonex and Hypoventilation - a phase IV clinical study of FDA data

Summary:

Hypoventilation is reported as a side effect among people who take Nasonex (mometasone furoate monohydrate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Singulair, and have Asthma.

The phase IV clinical study analyzes which people have Hypoventilation when taking Nasonex. It is created by eHealthMe based on reports of 31,171 people who have side effects when taking Nasonex from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Hypoventilation?

Hypoventilation (too shallow or too slow breathing, which does not meet the needs of the body) is found to be associated with 544 drugs and 631 conditions by eHealthMe. Check the latest studies of Hypoventilation.

On Jul, 07, 2026

31,171 people reported to have side effects when taking Nasonex.
Among them, 52 people (0.17%) have Hypoventilation.

Among these 52 people:

How long have people been on Nasonex when they have Hypoventilation? *

What is the gender of people who have Hypoventilation when taking Nasonex? *

female: 21.15 %
male: 78.85 %

What is the age of people who have Hypoventilation when taking Nasonex? *

What are other drugs people take besides Nasonex? *

What are other side effects people have besides Hypoventilation? *

Asthma: 43 people, 82.69%
Nasopharyngitis (inflammation of the nasopharynx): 42 people, 80.77%
Cough: 41 people, 78.85%
Dyspnea (difficult or laboured breathing): 36 people, 69.23%
Wheezing (a high-pitched whistling sound made while you breath): 35 people, 67.31%
High Blood Pressure: 33 people, 63.46%
Abdominal Pain: 32 people, 61.54%
Chest Pain: 32 people, 61.54%
Hypersensitivity: 32 people, 61.54%
Seasonal Allergy (allergic condition due to certain season): 30 people, 57.69%

What are the existing conditions these people have? *

Asthma: 45 people, 86.54%
Cystic Fibrosis (disease of the secretary glands): 2 people, 3.85%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 1.92%
Pain: 1 person, 1.92%
Nasal Polyps (masses that develop in the lining of the nose): 1 person, 1.92%
Nasal Obstruction (blockage of nose): 1 person, 1.92%
Mental Status Changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation): 1 person, 1.92%
Hypersensitivity: 1 person, 1.92%
High Blood Pressure: 1 person, 1.92%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 1.92%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and have Hypoventilation?

- Check whether Hypoventilation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasonex:

Nasonex (32,299 reports)

Hypoventilation treatments and more:

Hypoventilation (5,503 reports)

How severe was Hypoventilation and when was it recovered:

Hypoventilation in Nasonex

Expand to all the drugs that have ingredients of mometasone furoate monohydrate:

Hypoventilation and drugs with ingredients of mometasone furoate monohydrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nasonex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypoventilation:

Hypoventilation (544 drugs)

Browse all the conditions that are associated with Hypoventilation:

Hypoventilation (631 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mometasone furoate monohydrate (the active ingredients of Nasonex) and Nasonex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.